Target Modulation by a Kinase Inhibitor Engineered to Induce a Tandem Blockade of the Epidermal Growth Factor Receptor (EGFR) and c-Src: The Concept of Type III Combi-Targeting.

Autor: Rao, Suman1, Larroque-Lombard, Anne-Laure1, Peyrard, Lisa1, Thauvin, Cédric1, Rachid, Zakaria1, Williams, Christopher2, Jean-Claude, Bertrand J.1 bertrandj.jean-claude@mcgill.ca
Zdroj: PLoS ONE. Feb2015, Vol. 10 Issue 2, p1-24. 24p.
Databáze: Academic Search Ultimate